Pages that link to "Q93826796"

The following pages link to A comparison of methods for the molecular quantitation of the fourth component of human complement (Q93826796):

Displaying 50 items.

• Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A (Q24318713) (← links)
• Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution (Q24684822) (← links)
• Murine complement component C4 and sex-limited protein: identification of amino acid residues essential for C4 function (Q34292184) (← links)
• Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement (Q34537546) (← links)
• Activation of human complement by human lymphoid cells sensitized with histocompatibility alloantisera (Q34749973) (← links)
• Mechanisms of activation of the classical pathway of complement by Hageman factor fragment (Q35207230) (← links)
• Interaction of histocompatibility (HL-A) antibodies and complement with synchronized human lymphoid cells in continuous culture (Q36272301) (← links)
• Activation of the classical pathway of complement by Hageman factor fragment (Q36344568) (← links)
• Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway (Q36359927) (← links)
• Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serum (Q39323582) (← links)
• Alteration of Human Blood Cells and Changes in Plasma Mediators Produced by Radiographic Contrast Media (Q39536452) (← links)
• The Biology and Detection of Immune Complexes (Q39590911) (← links)
• Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo (Q39704644) (← links)
• Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin (Q39729130) (← links)
• Activation of the Complement System by Antibody-Antigen Complexes: The Classical Pathway (Q39856020) (← links)
• Cytotoxic effects of lymphoid cells in vitro (Q39905652) (← links)
• The Role of the Complement System in Rheumatoid Inflammation (Q39982272) (← links)
• Enzymic activity of the second component of complement (Q40346307) (← links)
• The in Vivo Metabolism of the Third Component of Complement in Systemic Lupus Erythematosus (Q40659228) (← links)
• Cold-dependent activation of complement: recognition, assessment, and mechanism. (Q41099974) (← links)
• A solid phase fluorescent immunoassay for the quantitation of the C4 component of human complement (Q41272029) (← links)
• Kinetics of the Agglutination of IgG-coated Latex Particles by Clq: the Influence of Heat-labile Serum Components (Q41590450) (← links)
• Purification of human complement subcomponent C4. C4 cleavage by C1s. (Q41734618) (← links)
• Molecular analysis of the membrane attack mechanism of complement (Q41785721) (← links)
• The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes (Q41838333) (← links)
• Synthesis of the second component of complement by long-term primary cultures of human monocytes (Q41854004) (← links)
• Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement (Q42019298) (← links)
• The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum (Q42154683) (← links)
• The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase (Q42833165) (← links)
• The reaction mechanism of human C5 in immune hemolysis (Q42835268) (← links)
• Production of ultrastructural membrane lesions by the fifth component of complement (Q42835417) (← links)
• The binding of human complement component C4 to antibody-antigen aggregates (Q42880845) (← links)
• Functional properties of heterogeneous human asialo-C4 and its isotypes C4A and C4B (Q44847257) (← links)
• Molecular titration of the fourth component of guinea-pig complement (Q45040912) (← links)
• Cleavage of the fourth component of human complement (C4) by C1 esterase: Isolation and characterization of the low molecular weight product (Q47390913) (← links)
• Phagocytes and C4 in Paraproteinaemia (Q67337245) (← links)
• The biochemistry of complement (Q67397602) (← links)
• Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18) (Q67728143) (← links)
• Difference in the biological properties of the two forms of the fourth component of human complement (C4) (Q68796680) (← links)
• Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a) (Q68803413) (← links)
• Functional and morphological characterization of cultures of Kupffer cells and liver endothelial cells prepared by means of density separation in Percoll, and selective substrate adherence (Q70096045) (← links)
• The ninth component of human complement: isolation, description and mode of action (Q70110738) (← links)
• Interaction between the Labile Binding Site of Human C4 and Methylamine (Q70776866) (← links)
• Isolation of Component C4 of Human Complement and Its Polypeptide Chains (Q70870583) (← links)
• The effect of trypsin cleavage on the structure and function of human C4 (Q70973292) (← links)
• C4 binding to artificial systems (Q71002829) (← links)
• Kinetic measurement of the interaction of rheumatoid factor with IgG-coated latex particles and the influence of the first component of human complement (Q71507788) (← links)
• The second component of human complement (C2): Quantitative molecular analysis of its reactions in immune hemolysis (Q71556205) (← links)
• Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera (Q72114395) (← links)
• The Effect of C4 on C1 Binding and Activation (Q72766085) (← links)